Monthly Archives: May 2025

C1 Takes the Stage: April Was a Month of Momentum

Last week, C1 hosted a powerful networking cruise across the Mediterranean, bringing together top leaders and partners aboard a luxury vessel with stops in Genoa, Marseille, and Barcelona.
This exclusive experience combined strategic business updates with rich cultural immersion — aligning with the company’s commitment to a cosmopolitan and forward-thinking approach to both life and enterprise.
Cruise Incentive Trip: Mediterranean Magic Unlocked
From April 20th to 24th, top leaders and partners sailed aboard a world-class cruise while soaking in luxury, recognition, and pure inspiration.

 Aboard Day 1 — Welcome, networking, and recognition as the C1 Mediterranean Cruise sets sail.
Global Updates and Visionary Leadership
Top leaders from across the globe received firsthand updates on C1’s latest product developments, ecosystem enhancements, and upcoming launches, ensuring the network remains informed, empowered, and aligned with the company’s global vision.
C1’s Cruise Incentive Trip initiative was a celebration of drive, leadership, and the unstoppable C1 spirit. The trip was full of bold announcements, visionary talks, and one-on-one time with the minds behind the movement.
By fostering business engagement in world-class settings, C1 continues to strengthen relationships, promote innovation, and build a unified international community.
Web3, Real-World Recognition, and Community Building
Incentives like this cruise are powerful accelerators for growing a Web3 business. In

Read more...

Zinzino Preliminary Sales Report, April 2025

Zinzino group revenue increased with a total of 54 %, compared with the previous year.
The revenue in April for Zinzino’s sales markets increased by 58 % and amounted to SEK 249.5 (158.0) million. Faun Pharma’s external sales decreased and amounted to SEK 6.2 (8.2) million.
Overall, the Group increased revenues by 54 % to SEK 255.7 (166.2) million compared with the previous year.
Accumulated revenue for January–April 2025 increased by 58 % to SEK 979.4 (620.7) million.
Revenues were distributed as follows:

Regions (MSEK)
Apr 2025 
Apr 2024 
Change 
YTD 2025 
YTD 2024 
Change 

The Nordics
23.5
25.0
-6%
100.7
93.0
8%

Central Europe
65.6
45.5
44%
262.0
165.0
59%

East Europe
27.2
31.1
-13%
124.4
124.9
0%

South & West Europe
45.0
26.4
70%
169.9
97.1
75%

The Baltics
8.7
8.2
6%
37.4
32.0
17%

North America
51.5
15.3
237%
164.0
50.7
223%

Asia-Pacific
26.3
5.4
387%
92.1
17.8
417%

Africa
1.7
1.1
55%
6.7
4.4
52%

Zinzino
249.5
158.0
58%
957.2
584.9
64%

Faun Pharma
6.2
8.2
-24%
22.2
35.8
-38%

Zinzino Group
255.7
166.2
54%
979.4
620.7
58%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

Central Europe: Austria, Germany, Switzerland

East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

The Baltics: Estonia, Latvia, Lithuania

North America: Canada, USA, Mexico

Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand

Africa: South Africa

To view the full press release, please visit zinzino.com
About Zinzino
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven

Read more...